Related Experiment Video
Updated: May 6, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Rectal mucosal plasma cells in inflammatory bowel disease
Plasma cell counts in rectal biopsies increase with inflammatory bowel disease severity. These changes are a non-specific response to mucosal damage, not indicative of specific disease types like ulcerative proctocolitis or Crohn's colitis.
Area of Science:
- Gastroenterology
- Immunohistochemistry
- Pathology
Background:
- Plasma cells play a crucial role in mucosal immunity.
- Accurate quantification of plasma cells is essential for understanding inflammatory conditions.
- The immunoperoxidase technique requires optimized antibody titration for reliable results.
Purpose of the Study:
- To optimize the immunoperoxidase technique for reproducible plasma cell counting in paraffin-embedded tissues.
- To investigate the levels of IgA, IgM, IgE, and IgG plasma cells in various rectal inflammatory conditions.
- To correlate plasma cell counts with histological features of inflammatory bowel disease.
Main Methods:
- Optimized immunoperoxidase staining with antisera titration for plateau counts.
- Analysis of rectal biopsies from control subjects and patients with ulcerative proctocolitis, Crohn's colitis, non-specific proctitis, bacterial colitis, and Crohn's disease without large bowel involvement.
- Correlation of plasma cell counts (IgA, IgM, IgE, IgG) with disease severity and histological findings.
Main Results:
- A baseline ratio of IgA:IgM:IgE:IgG plasma cells was established in controls (8:3:3:1).
- Significantly increased plasma cell counts were observed in ulcerative proctocolitis, Crohn's colitis, and non-specific proctitis, correlating with inflammation severity.
- Bacterial colitis showed elevated IgA and IgE plasma cells compared to controls; no significant differences were found when matched for inflammation severity with inflammatory bowel disease.
Conclusions:
- Increased plasma cell counts in inflammatory bowel disease are a non-specific response to mucosal damage.
- The observed changes in plasma cell populations do not differentiate between specific types of inflammatory bowel disease.
- A luminal irritant may contribute to the non-specific increase in plasma cells observed in inflammatory bowel disease.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations

